These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7538236)

  • 21. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
    Lintula S; Stenman J; Bjartell A; Nordling S; Stenman UH
    Prostate; 2005 Jun; 63(4):324-9. PubMed ID: 15599939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
    Haese A; Graefen M; Palisaar J; Huland E; Huland H
    Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.
    Nam RK; Diamandis EP; Toi A; Trachtenberg J; Magklara A; Scorilas A; Papnastasiou PA; Jewett MA; Narod SA
    J Clin Oncol; 2000 Mar; 18(5):1036-42. PubMed ID: 10694554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.
    Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A
    Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of prostate-specific antigen.
    Lilja H
    Urology; 2003 Nov; 62(5 Suppl 1):27-33. PubMed ID: 14607215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.
    Stephan C; Jung K; Diamandis EP; Rittenhouse HG; Lein M; Loening SA
    Urology; 2002 Jan; 59(1):2-8. PubMed ID: 11796270
    [No Abstract]   [Full Text] [Related]  

  • 28. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
    Lawrence MG; Lai J; Clements JA
    Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen: what's new in 1997.
    Pannek J; Partin AW
    Oncology (Williston Park); 1997 Sep; 11(9):1273-8; discussion 1279-82. PubMed ID: 9306417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
    Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A
    Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
    Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH.
    Abrahamsson PA; Kuriyama M
    Hinyokika Kiyo; 1998 Apr; 44(4):223-32. PubMed ID: 9617617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen).
    Heuzé-Vourc'h N; Leblond V; Courty Y
    Eur J Biochem; 2003 Feb; 270(4):706-14. PubMed ID: 12581210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
    Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ
    Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Saeid MS; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1999 May; 53(5):939-44. PubMed ID: 10223487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
    Olsson AY; Lilja H; Lundwall A
    Genomics; 2004 Jul; 84(1):147-56. PubMed ID: 15203212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.
    Henttu P; Lukkarinen O; Vihko P
    Int J Cancer; 1990 Apr; 45(4):654-60. PubMed ID: 1691151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen and new related markers for prostate cancer.
    Daher R; Beaini M
    Clin Chem Lab Med; 1998 Sep; 36(9):671-81. PubMed ID: 9804390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.